Form D · Pharmaceuticals

Pierrepont Therapeutics, Inc.

Brooklyn, NY · CIK 0002019360

Offering snapshot reported Sep 22, 2026 · SEC filing

Reported sold
$2.41M
Offering amount: $5.86M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 2, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.2M$2.41MApr 15, 2024: $2,109,876.00Apr 15, 2024Sep 22, 2026: $2,409,876.00Sep 22, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,109,876 → $2,409,876

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 22, 2026Amendment$2,409,876$300,000vs Apr 15, 20242SEC filing
Apr 15, 2024Initial$2,109,876No comparison2SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-510659

Source: Form D, filed Sep 22, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Peter H. Barber Director, Executive
Daniel Di Pietro Director
Matthew Wyckoff Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
Downstate Technology Center, Suite 327 A 760 Parkside Avenue
Brooklyn, NY, 11203
Phone: 212-430-1740